C4a: the third anaphylatoxin of the human complement system
- PMID: 291947
- PMCID: PMC413129
- DOI: 10.1073/pnas.76.10.5299
C4a: the third anaphylatoxin of the human complement system
Abstract
The activation peptide C4a was isolated from C1s-cleaved C4, the fourth component of complement. The peptide appeared to be homogeneous by electrophoresis on cellulose acetate and by polyacrylamide gel electrophoresis. C4a has a molecular weight of 8650 and an electrophoretic mobility at pH 8.6 of +2.1 x 10(-5) cm2V-1 sec-1. Carboxypeptidase B released approximately 1 mol of arginine per mol of C4a. The partial COOH-terminal sequence was determined to be Leu-Gln-Arg-COOH. The isolated C4a was spasmogenic for guinea pig ileum at a concentration of 1 microM and it desensitized the muscle (i.e., produced tachyphylaxis) with respect to human C3a anaphylatoxin (at 0.33 microM) but not with respect to human C5a anaphylatoxin. Increased vascular permeability was observed in human skin after intradermal injection of 1 nmol of C4a, as evidenced by immediate erythema and edema formation. The spasmogenic, tachyphylactic, and vascular activities of C4a were abrogated by removal of the COOH-terminal arginine, a property that is characteristic also of the C3a and C5a anaphylatoxins. Contamination of C4a with either C3a or C5a has been ruled out by using radioimmunoassays for these peptides. Although C4a is considerably less active than are C3a and C5a, the present observations suggest that C4a constitutes a heretofore unrecognized anaphylatoxin that is related biologically and chemically to the activation peptides of C3 and C5.
Similar articles
-
The active site of human C4a anaphylatoxin.Mol Immunol. 1983 Jun;20(6):637-45. doi: 10.1016/0161-5890(83)90008-1. Mol Immunol. 1983. PMID: 6603573
-
Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.Proc Natl Acad Sci U S A. 1981 Mar;78(3):1833-7. doi: 10.1073/pnas.78.3.1833. Proc Natl Acad Sci U S A. 1981. PMID: 6940191 Free PMC article.
-
Structural characterization of the C4a anaphylatoxin from rat.Mol Immunol. 1988 Jul;25(7):663-71. doi: 10.1016/0161-5890(88)90101-0. Mol Immunol. 1988. PMID: 3262196
-
Biochemistry and biology of anaphylatoxins.Complement. 1986;3(3):111-27. doi: 10.1159/000467889. Complement. 1986. PMID: 3542363 Review.
-
The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.Crit Rev Immunol. 1981 Feb;1(4):321-66. Crit Rev Immunol. 1981. PMID: 7037298 Review. No abstract available.
Cited by
-
Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress.Thromb Res. 2008;122(2):221-8. doi: 10.1016/j.thromres.2007.11.005. Epub 2007 Dec 31. Thromb Res. 2008. PMID: 18166221 Free PMC article.
-
Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.Front Immunol. 2021 Apr 28;12:642860. doi: 10.3389/fimmu.2021.642860. eCollection 2021. Front Immunol. 2021. PMID: 33995361 Free PMC article.
-
In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.Clin Exp Immunol. 1988 Mar;71(3):486-92. Clin Exp Immunol. 1988. PMID: 3260158 Free PMC article.
-
Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).Clin Exp Immunol. 1986 May;64(2):407-14. Clin Exp Immunol. 1986. PMID: 3488858 Free PMC article.
-
Receptors for complement components in inflammation.Agents Actions. 1983 Aug;13(5-6):398-405. doi: 10.1007/BF02176402. Agents Actions. 1983. PMID: 6637663 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous